Kathleen Molpus

Statistics

Publications

Citations

658

H-Index

Active since

2000

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Kathleen Molpus is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, pharmacokinetics of anticancer drugs, and pharmacokinetics of anticancer agents.

Publications per year

2000–2014

Publications

Phase I and Pharmacokinetic Study of XRP6258 (RPR 116258A), a Novel Taxane, Administered as a 1-Hour Infusion Every 3 Weeks in Patients with Advanced Solid Tumors

Alain C. Mita, Louis Denis, Eric K. Rowinsky et al. · Clinical Cancer Research · 2009 · 332 citations

Medicine, Oncology, Pharmacology +16

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Alain C. Mita, Christopher J. Sweeney, Sharyn D. Baker et al. · Journal of Clinical Oncology · 2006 · 113 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer

Giorgio V. Scagliotti, Igor Bondarenko, Fiona Blackhall et al. · Annals of Oncology · 2014 · 66 citations · Full text

Medicine, Oncology, Pharmacology +13

Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate.

Marco Del Governatore, Michael R. Hamblin, Christopher R. Shea et al. · PubMed · 2000 · 57 citations

Medicine, Oncology, Pharmacology +14

Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine S-1 on a Once-Daily-for-28-Day Schedule in Patients with Advanced Malignancies

Quincy Chu, Lisa A. Hammond, Garry Schwartz et al. · Clinical Cancer Research · 2004 · 48 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 6